Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

5 terminated/withdrawn out of 35 trials

Success Rate

84.4%

-2.1% vs industry average

Late-Stage Pipeline

23%

8 trials in Phase 3/4

Results Transparency

56%

15 of 27 completed trials have results

Key Signals

2 recruiting15 with results

Enrollment Performance

Analytics

N/A

10(37.0%)

Phase 4

5(18.5%)

Phase 2

5(18.5%)

Phase 1

4(14.8%)

Phase 3

3(11.1%)

27Total

N/A(10)

Phase 4(5)

Phase 2(5)

Phase 1(4)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials

NCT05165888Not ApplicableCompleted

Targeting Bias to Reduce Disparities in End of Life Care

Role: collaborator

NCT04704050Phase 4Terminated

Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence

Role: lead

NCT04199000Recruiting

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Role: collaborator

NCT01418014Completed

Adolescent Master Protocol

Role: collaborator

NCT02119702Completed

Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)

Role: collaborator

NCT01310023Completed

Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

Role: collaborator

NCT04703166Recruiting

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

Role: lead

NCT01084096Not ApplicableCompleted

Trial of the Use of Antenatal Corticosteroids in Developing Countries

Role: collaborator

NCT04866953Completed

UltraMTP in Adult Trauma Patients Undergoing Surgery Within 24 Hours: Effects on Mortality and Clinical Outcomes

Role: collaborator

NCT02529319Not ApplicableCompleted

Efficacy of Delayed Enhancement MRI-Guided Ablation vs Conventional Catheter Ablation of Atrial Fibrillation

Role: lead

NCT02046395Phase 4Completed

Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus

Role: lead

NCT01274026Completed

Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders

Role: lead

NCT02453373Not ApplicableTerminated

Helping Stroke Patients With ThermoSuit Cooling

Role: collaborator

NCT03229551Phase 2Completed

Xylitol for Chronic Sinusitis

Role: collaborator

NCT04347811Not ApplicableCompleted

Use of Death Cafes to Prevent Burnout in ICU Healthcare Employees

Role: lead

NCT02796170Phase 4Completed

Inhibition of Urinary Angiotensinogen and the Reduction of Blood Pressure by SGLT2 Inhibition in Patients With Type 2 Diabetes

Role: lead

NCT05170789Phase 2Withdrawn

Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma

Role: lead

NCT04305353Not ApplicableCompleted

Intensive Care Unit (ICU) Diary Project

Role: lead

NCT02299388Phase 4Completed

To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study

Role: lead

NCT03305081Not ApplicableTerminated

Patient Compliance With Long-Acting Reversible Contraception Administration

Role: lead